Get started
Author

Joseph Zahn

Altered Rb, p16, and p53 expression is specific for porocarcinoma relative to poroma
2019 · Joseph Zahn, May P. Chan, et al. · Journal of Cutaneous Pathology · 33
Dupilumab reduces inflammatory biomarkers in pediatric patients with moderate-to-severe atopic dermatitis
2024 · Lisa A. Beck, Antonella Muraro, et al. · Journal of Allergy and Clinical Immunology · 29
Dupilumab treatment restores lesional and nonlesional skin barrier function in adults and adolescents with atopic dermatitis irrespective of the filaggrin genotype: Results from an open-label, healthy-control–matched, phase 4 clinical study (BALISTAD)
2025 · Robert Bissonnette, Elena Goleva, et al. · Journal of the American Academy of Dermatology · 11
Responder analysis using clinically meaningful thresholds: Post hoc analyses from randomized dupilumab clinical trials in patients with prurigo nodularis
2024 · Shawn G. Kwatra, Gil Yosipovitch, et al. · Journal of the European Academy of Dermatology and Venereology · 11
Efficacy and Safety of Dupilumab in Adults with Prurigo Nodularis with or Without Atopic Comorbidities: A Subgroup Analysis from Two Randomized Phase III Clinical Trials
2025 · Brian S. Kim, Margarida Gonçalo, et al. · American Journal of Clinical Dermatology · 9
PDF
Longitudinal integrated proteomic and metabolomic skin changes in patients with atopic dermatitis treated with dupilumab
2025 · Elena Goleva, Evgeny Berdyshev, et al. · Journal of Allergy and Clinical Immunology · 9
Nano‐encapsulated anandamide reduces inflammatory cytokines in vitro and lesion severity in a murine model of cutaneous lupus erythematosus
2023 · Erika T. McCormick, Andrew Draganski, et al. · Experimental Dermatology · 8
Dupilumab Improves Skin Lipid Barrier in Pediatric Patients With Moderate-to-Severe Atopic Dermatitis
2024 · Irina Bronova, Evgeny Berdyshev, et al. · Journal of Allergy and Clinical Immunology · 6
Prurigo Nodularis PaTient-Reported BurdEn of SicKness (PN TREK): A Cross-Sectional Survey of Patient-Reported Burden of Disease in Patients with PN from the US
2025 · Shawn G. Kwatra, Min Yang, et al. · Advances in Therapy · 5
PDF
Dupilumab treatment restores epithelial barrier in nonlesional and lesional skin in children with atopic dermatitis
2026 · Michael J. Cork, Peck Y. Ong, et al. · Annals of Allergy Asthma & Immunology · 3
PDF
Benign familial pemphigus treated with lebrikizumab
2026 · Harisankeerth Mummareddy, Nagasai C. Adusumilli, et al. · JAAD Case Reports · 3
Offering an Off-Label Therapeutic Algorithm for Lichen Planus.
2022 · Dillon Nussbaum, Jessica Kalen, et al. · PubMed · 3
P036 Dupilumab treatment normalizes skin barrier function in children aged 6–11 years with moderate-to-severe atopic dermatitis
2024 · Michael J Cork, Donald Leung, et al. · British Journal of Dermatology · 2
Successful Treatment of Lichen Amyloidosis Using a Fixed Combination of Halobetasol-Propionate and Tazarotene Lotion
2021 · Ezra Shoen, Angela Hou, et al. · Journal of Drugs in Dermatology · 2
PDF
Dupilumab Efficacy In Pooled LIBERTY-CSU CUPID Study A And Study C Regardless Of Baseline Serum Total IgE Levels
2026 · Sarbjit Saini, Thomas Casale, et al. · Journal of Allergy and Clinical Immunology · 1
Dupilumab Reduces Pruritus in Clinically Distinct Dermatologic Diseases: Data from Clinical Trials on Atopic Dermatitis, Prurigo Nodularis, and Chronic Spontaneous Urticaria
2025 · Gil Yosipovitch, Brian S. Kim, et al. · Dermatology and Therapy · 1
PDF
61982 Dupilumab normalizes filaggrin processing and improves clinical outcomes in children with moderate-to-severe atopic dermatitis
2025 · Elena Goleva, Evgeny Berdyshev, et al. · Journal of the American Academy of Dermatology · 1
63281 Real-World Comorbidities of Adult Patients With Prurigo Nodularis Initiating Dupilumab in the US
2025 · Nicholas Mollanazar, Danielle L. Isaman, et al. · Journal of the American Academy of Dermatology · 1
Dupilumab Efficacy in Children with Atopic Dermatitis with Different Phenotypes and Endotypes: A Case Series
2025 · Ana B. Rossi, Adriana M. Mello, et al. · Advances in Therapy · 1
52273 Dupilumab Provides Sustained Normalization of Skin Barrier Function in Children With Moderate-to-Severe Atopic Dermatitis
2024 · Michael J. Cork, Evgeny Berdyshev, et al. · Journal of the American Academy of Dermatology · 1
PDF
635 - Dupilumab is efficacious in patients with prurigo nodularis regardless of baseline lesion severity: pooled results from two phase 3 trials (LIBERTY-PN PRIME and PRIME2)
2024 · Sonja Ständer, Laurent Misery, et al. · British Journal of Dermatology · 1
508 - Dupilumab treatment normalizes intraepidermal nerve fiber density in patients with moderate-to-severe AD
2024 · Sonja Ständer, Konstantin Agelopoulos, et al. · British Journal of Dermatology · 1
Is TNF-α Inhibitor-Induced Psoriasiform Dermatitis Always Psoriasiform?
2020 · Chapman Wei, Emily C Murphy, et al. · PubMed · 1
A Case of Adjacent, Clonally Distinct Borderline Melanocytic Tumors on the Arm
2019 · Andrew Schuler, Mallory Smith, et al. · American Journal of Dermatopathology · 1
Delgocitinib 20 mg/g cream for the treatment of lichen planopilaris: A case report
2026 · Mina Farah, Nikkia Zarabian, et al. · JAAD Case Reports
Works count: 83
Citation count: 143
H-index: 7
I10-index: 4
Year
Topic
Type